Moncef Slaoui, who served as chief scientist for the Operation Warp Speed response to the Covid-19 pandemic under former President Donald Trump, was fired as chairman of the board of directors of Galvani Bioelectronics following the “substantiation” of allegations of sexual harassment and inappropriate conduct.
Centessa, based in Cambridge, Mass. and London, launched as a “novel asset-centric pharmaceutical company.”
Perhaps the synergy of federal spending and pharma/biotech ingenuity we witnessed during Operation Warp Speed should continue beyond the COVID-19 pandemic to address other medical crises. Turning the race for a vaccine into something like the 1889 Oklahoma land rush was a masterstroke.
Merck is stopping development of the company’s two Covid-19 vaccine candidates, dubbed V590 and V591, after poor responses in Phase I trials.
Moncef Slaoui, the GlaxoSmithKline vaccines veteran who has helmed the federal government’s Operation Warp Speed Covid-19 vaccine program, is stepping down from the role ahead of the inauguration of President-elect Joe Biden.
U.S. firm Johnson & Johnson is likely to apply for EU approval for the company’s Covid-19 vaccine candidate in February, a top lawmaker said.
U.S. endures pandemic’s deadliest day, overshadowed by Washington mob assault on Capitol
"Operation Warp Speed" Initiative, California, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Vaccinations, Covid-19 Variants, Data, Death Tolls, Department of Health and Human Services (HHS), Donald Trump, Health Officials, Hospitalized COVID-19 Patients, Nevada, New Hampshire, Oklahoma, Pennsylvania, Pharmacies, Phil Murphy (NJ), Reuters Analysis, Reuters Tally, U.S. Health Secretary Alex Azar, United KingdomAs the events that unfolded in Washington on Jan. 6 captured the nation’s attention, the raging coronavirus pandemic claimed its highest U.S. death toll yet, killing more than 4,000 people in a single day according to a Reuters tally.
Studies to see if Moderna Covid-19 vaccine doses can be halved may take two months
"Operation Warp Speed" Initiative, COVID-19 cases, FDA, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), National Institutes of Health, The New York Times, U.S. Centers for Disease Control and Prevention, U.S. governmentScientists at the National Institutes of Health and Moderna Inc. may take about two months to determine whether doses of the company’s Covid-19 vaccine can be halved to double the supply of the shots in the U.S., according to the agency.
The U.S. Food and Drug Administration warned health care personnel not to make any changes to the dosing of Covid-19 vaccines and that doing so would place the public health at risk and undermine “the historic vaccination effort to protect the population.”
As Operation Warp Speed – the Trump administration’s program to develop and distribute a Covid-19 vaccine – struggles to ramp up vaccinations, one of the approaches under consideration is cutting the doses of the Moderna vaccine.